Vijaya Diagnostic Centre

What Vijaya Diagnostic Centre does

Vijaya Diagnostic Centre is an Indian organized diagnostic services chain headquartered in Hyderabad, founded in 1981 and listed on the NSE under ticker VIJAYA. The company provides pathology and radiology diagnostic testing services to individual patients through a network of 162 owned diagnostic centers across India, operating a B2C integrated model with approximately 37% of revenue derived from radiology and the balance from pathology and related services. Customer acquisition relies on direct walk-ins, physician referrals, and a growing wellness/preventive health segment that includes corporate wellness programs.

The business model is transaction-fee based: Vijaya earns revenue per diagnostic test ordered, with no public pricing disclosure but pricing implied to vary by test type. The company scales through geographic hub expansion, new center openings, and acquisitions that have built the network to 162 centers, supported by pre-IPO institutional capital from Kedaara Capital. FY26 sales reached Rs 814.20 crore, with Q4 FY26 quarterly revenue of Rs 219.38 crore (up 26.63% YoY) and net profit of Rs 47.93 crore (up 37.49% YoY), reflecting strong operating leverage from volume growth. As a healthcare services provider, Vijaya does not sell software, APIs, or technology products; its core technology stack is the clinical diagnostic infrastructure (pathology labs and radiology imaging) rather than disclosed AI or platform technology.

The company is led by founder and Executive Chairman Surendranath Reddy and CEO Suprita Reddy, with ownership distributed across public shareholders. The company is currently navigating a leadership transition, with both the CFO and CTO having announced resignations in June 2026 effective July and August 2026 respectively, with no named successors disclosed.

Name

Vijaya Diagnostic Centre

Legal name

Vijaya Diagnostic Centre Ltd

Website

https://vijayadiagnostic.com

Company type

Public

Founded year

1981

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Vijaya Diagnostic Centre is an Indian listed diagnostic chain operating 162 centers that provide pathology and radiology testing services to individual patients under a B2C integrated model, generating Rs 814.20 crore in FY26 revenue.

Ownership category

akta.pro rank

Product category

Diagnostic Services

NAICS

Medical and Diagnostic Laboratories (62151), Diagnostic Imaging Centers (621512), Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Ambulatory Cardiology Diagnostic & Procedure Centers (Non-hospital-based) (HLAFABAK)

Keywords

• Diagnostic services
• Pathology testing
• Radiology imaging
• Preventive health checkups
• Clinical laboratory

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Diagnostic Testing Services: Revenue generated from providing diagnostic testing services including pathology and radiology. The company operates 162 diagnostic centers with 37% radiology revenue mix. Q4 FY26 revenue was Rs 219.38 crore with 26.63% growth.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Vijaya Diagnostic Centre provides integrated diagnostic testing services, primarily pathology (blood tests and clinical pathology) and radiology (imaging) services, to individual patients and wellness-segment customers. The company operates 162 owned diagnostic centers across India where patients can access tests on a walk-in basis, with radiology comprising approximately 37% of total revenue. In addition to routine diagnostic testing, the company offers preventive health checkups and supports corporate wellness programs.

Product overview

Vijaya Diagnostic Centre is a healthcare diagnostic services provider operating in India. Based on available sources, the company operates a B2C integrated diagnostic model with a focus on both radiology and pathology services. The company has expanded to 162 diagnostic centers across key markets, with radiology comprising approximately 37% of revenue. Financial sources indicate the company reported quarterly revenue of Rs 219 crore with 21-27% year-over-year revenue growth and 37-38% profit growth in recent quarters. However, detailed product specifications, named product offerings, or service module documentation are not available in the provided sources.

Differentiator

Problem solved

Functional benefit

Products and services

• Pathology Testing Services
• Radiology Imaging Services
• Preventive Health Checkups and Wellness Programs

Quantifiable outcome

• Revenue grew 27% YoY in Q4 FY26
• +3 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators8 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Dr. Lal PathLabs: India's largest listed diagnostic chain with a national network of patient service centers and labs offering pathology and radiology. Closest direct comparable to Vijaya on listed status, B2C walk-in model, and multi-modality services.
• Metropolis Healthcare: Listed Indian diagnostic chain providing pathology and radiology testing across multiple cities with strong B2C franchise. Directly comparable to Vijaya on revenue mix, geographic expansion model, and listed peer-multiple benchmark.
• Apollo Diagnostics: Diagnostic arm of Apollo Hospitals, operating a national network of diagnostic centers spanning pathology and radiology. Directly competes with Vijaya in walk-in B2C diagnostics and leverages a hospital brand for trust and referrals.
• Agilus Diagnostics (formerly SRL Diagnostics): One of India's largest diagnostic chains (formerly SRL, owned by Agilus), with pan-India center and reference-lab coverage in pathology and radiology. Direct competitor in both B2C centers and B2B reference-lab relationships.
• Thyrocare Technologies: Listed Indian diagnostics business now backed by PharmEasy, focused on high-volume low-cost pathology with a hub-and-spoke B2B/B2C model. Comparable to Vijaya on listed status; differentiated by aggregator-backed fulfillment model.
• Suburban Diagnostics: Regional diagnostic chain with strong presence in western India offering pathology, radiology, and home sample collection. Comparable to Vijaya as a multi-modality regional chain pursuing geographic expansion in B2C diagnostics.
• Neuberg Diagnostics: Pan-India integrated diagnostic chain with regional lab partners offering pathology, radiology, and wellness packages. Direct peer on multi-modality B2C center model and franchise/partner-led geographic expansion.

Regional players

• Kashi Diagnostics (Hyderabad): Hyderabad-headquartered regional diagnostic chain competing directly with Vijaya in its home market across pathology, radiology, and home services. Relevant peer for share-of-wallet analysis in Vijaya's anchor geography.

Emerging players

• Healthians: Tech-led at-home diagnostics and wellness platform with an online booking layer and partner phlebotomist network. Emerging peer whose aggregator model competes with Vijaya's walk-in B2C franchise for first-mile customer acquisition.
• Tata 1mg: Tata Group-backed online healthcare platform offering diagnostic test booking and home sample collection alongside pharmacy. Comparable on diagnostic services and wellness packages, differentiated by online-first aggregator model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/VdcConnect
• Facebookfacebook.com/VdcConnect
• LinkedInlinkedin.com/company/vdcconnect

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vijaya Diagnostic Centre